NCT07029555View on ClinicalTrials.gov

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

PHASE1RecruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

May 15, 2028

Study Completion Date

May 16, 2028

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

PIT565

Study treatment will be provided in vials as open-label participant specific supply.

Trial Locations (9)

1618

RECRUITING

Novartis Investigative Site, Sofia

11658

RECRUITING

Novartis Investigative Site, Bucharest

55131

RECRUITING

Novartis Investigative Site, Mainz

100191

RECRUITING

Novartis Investigative Site, Beijing

100730

RECRUITING

Novartis Investigative Site, Beijing

400006

RECRUITING

Novartis Investigative Site, Cluj-Napoca

07740

RECRUITING

Novartis Investigative Site, Jena

2333 CL

RECRUITING

Novartis Investigative Site, Leiden

08035

RECRUITING

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY